home
portfolio
team
careers
contact
investor portal
home
portfolio
team
careers
contact
investor portal
Nextech Invest
Turning Point Therapeutics Announces Appointment of Steve Sabus as Chief Commercial Officer
Turning Point Therapeutics Announces Appointment of Steve Sabus as Chief Commercial Officer
Post navigation
Previous Post
Previous
Cullinan Oncology Provides Corporate Update and Reports First Quarter 2022 Financial Results
Next Post
Next
Exo Therapeutics Appoints Stephanos Ioannidis as Executive Vice President, Drug Discovery and Catherine Scholz as Senior Vice President, Program Management